Is ABAX a buy? - Seeking Alpha

Quote & Headlines Market Currents StockTalk

Today 5d 1m 3m 1y 5y 10y

52wk high:

52wk low:

EPS:

PE:

Div Rate:

Yield:

Market Cap:

Volume:

213 people get ABAX articles and Market Currents by email alert.

Get email alerts on ABAX »

FOCUS | PRO | RELATED | TRANSCRIPTS | NEWS & PR

Abaxis: Buy The Market's Oversight
QuandaryFX • Tue, Nov 27, 2012
2 Reasons To Consider Abaxis In The Wake Of A Recent Downgrade
Matt Schilling • Tue, Sep 25, 2012 • 2 Comments
Abaxis: Aggressive Growth Stock With Bright Prospects Ahead
Zacks Investment Research • Wed, Jul 11, 2012
Abaxis CEO Speaks About His Company
The Wall Street Transcript • Tue, Feb 26, 2008

To learn more about Seeking Alpha Pro, click here.

Heska Provides Investors Low Risk / High Reward Opportunity In Companion Animal Space
Paul Nouri • Tue, Jun 11 • 2 Comments
10 High-Growth Healthcare Stocks With Strong Inventory Trends
Kapitall • Tue, Sep 18, 2012
7 Low-Debt Small Cap Healthcare Stocks Positioned For Growth
ZetaKap • Tue, Aug 21, 2012 • 1 Comment
12 Highly Liquid Healthcare Stocks With Strong Sales Trends
Kapitall • Tue, Jul 3, 2012
4 Small Cap Healthcare Stocks Armed With Cash And Set For Growth
ZetaKap • Mon, Jun 25, 2012 • 7 Comments
Zoetis Spin-Off Could Be Big For Pfizer
Ry Frank • Thu, Jun 14, 2012 • 1 Comment
6 Small Cap Stocks With Plenty Of Cash On Hand And Strong Expected Growth
ZetaKap • Thu, May 24, 2012
6 Low-Debt Healthcare Stocks That Analysts Rate As Buy Or Better
ZetaKap • Thu, May 17, 2012
9 High-Growth Healthcare Stocks With Strong Inventory Trends
Kapitall • Thu, May 17, 2012
6 Cash Heavy Small-Cap Healthcare Stocks Rated As Buys
ZetaKap • Thu, May 10, 2012 • 1 Comment
6 Cash Heavy Small-Cap Stocks Rated Buy Or Better
ZetaKap • Wed, May 9, 2012
6 Small Cap Stocks Hoarding Cash And Holding Buy Ratings
ZetaKap • Tue, May 8, 2012 • 1 Comment
11 Small Caps Trading Near Highs With Strong Inventory Trends
Kapitall • Thu, May 3, 2012 • 1 Comment
Consolidation Continues In Mid Cap DX Companies: Bull Market In Biotech Hits New Highs
Rod Raynovich • Wed, May 2, 2012 • 2 Comments
Corgenix Medical Should Quickly Recoup Revenue Miss
Brian Marckx • Tue, Nov 15, 2011
Life Science Portfolios: Reflecting on a Year of Out-Performance
Rod Raynovich • Wed, Dec 29, 2010 • 1 Comment
Best Performing Stocks on Earnings
Bespoke Investment Group • Tue, Apr 13, 2010
My Dog Has Turned Me Into a Jackass: 7 Companion Animal Stocks Worth Watching
Alan Brochstein • Mon, Feb 22, 2010 • 11 Comments
Biotech: Q3 Market Update
R. Scott Raynovich • Fri, Oct 16, 2009 • 1 Comment
A Trend System for Stocks and ETFs
Scott's Investments • Fri, Aug 14, 2009 • 4 Comments

ABAXIS CEO Discusses Q4 2013 Results - Earnings Call Transcript
Thu, Apr 25
Abaxis' CEO Discusses Q3 2013 Results - Earnings Call Transcript
Thu, Jan 31
Abaxis CEO Discusses F2Q2011 Results - Earnings Call Transcript
Tue, Oct 26, 2010
Abaxis Inc. F1Q11 (Qtr End 06/30/10) Earnings Call Transcript
Thu, Jul 29, 2010
Abaxis, Inc. F4Q10 (Qtr End 03/31/10) Earnings Call Transcript
Mon, May 3, 2010
Abaxis, Inc. F3Q09 (Qtr End 12/31/08) Earnings Call Transcript
Thu, Jan 29, 2009
Abaxis, Inc. F2Q09 (Qtr End 09/30/08) Earnings Call Transcript
Mon, Nov 3, 2008
Abaxis, Inc. Q4 2008 Earnings Call Transcript
Fri, May 30, 2008
Abaxis Inc. F3Q08 (Qtr End 12/31/07) Earnings Call Transcript
Thu, Jan 31, 2008

Abaxis, Inc. to Present at the Jefferies 2013 Global Healthcare Conference

PR Newswire (May 29, 2013)
Abaxis, Inc. to Present at the Stifel Annual Dental & Veterinary Conference

PR Newswire (May 21, 2013)
Abaxis, Inc. to Present at the Bank of America Merrill Lynch 2013 Health Care Conference

PR Newswire (May 8, 2013)
Abaxis Reports Financial Performance For The Fourth Quarter And Fiscal 2013

PR Newswire (Apr 25, 2013)
Abaxis To Report Fourth Quarter And Fiscal Year 2013 Financial Results Thursday, April 25, 2013

PR Newswire (Apr 17, 2013)
Abaxis, Inc. to Present at the Sidoti & Company Seventeenth Annual Institutional Investor Forum

PR Newswire (Mar 11, 2013)
Abaxis, Inc. to Present at the Raymond James 34th Annual Institutional Investor Conference

PR Newswire (Feb 25, 2013)
Abaxis to Present at Lazard Capital Markets 5th Annual Medical Technology Snowbird Conference

PR Newswire (Feb 15, 2013)
Abaxis Reports Record Revenues For The Third Quarter Of Fiscal 2013

PR Newswire (Jan 31, 2013)
Abaxis To Report Third Quarter Fiscal Year 2013 Financial Results Thursday, January 31, 2013

PR Newswire (Jan 23, 2013)
Abaxis Declares Special Cash Dividend of $1.00 Per Share

PR Newswire (Dec 6, 2012)
Abaxis, Inc. to Present at 24th Annual Piper Jaffray Healthcare Conference

PR Newswire (Nov 20, 2012)
Abaxis, Inc. to Participate in Sidoti & Company's Inaugural One-on-One Conference

PR Newswire (Nov 13, 2012)
Abaxis, Inc. to Present at the Stephens Fall Investment Conference

PR Newswire (Nov 7, 2012)
Abaxis, Inc. to Present at the Lazard Capital Markets 9th Annual Healthcare Conference

PR Newswire (Nov 6, 2012)
Abaxis Announces Exclusive Distribution Agreement with Abbott

PR Newswire (Oct 31, 2012)
Abaxis Reports Financial Performance For The Second Quarter Of Fiscal 2013

PR Newswire (Oct 23, 2012)
Abaxis To Report Second Quarter Fiscal Year 2013 Financial Results Tuesday, October 23, 2012

PR Newswire (Oct 16, 2012)
Abaxis Announces Distribution Agreement with MWI Veterinary Supply

PR Newswire (Oct 1, 2012)
Abaxis Announces Settlement of Patent Litigation With Cepheid

PR Newswire (Sep 26, 2012)

ABAX vs. ETF Alternatives

Company Description

Currently, there's no company description for ABAX.

Sector: Healthcare

Industry: Diagnostic Substances

Country: United States

All
| Earnings
| Dividends
| M&A
| On the move

Thursday, April 25, 6:07 PM More on Abaxis (ABAX): Q1 beats on a per share basis but misses on revenue, despite a 17% Y/Y rise in total sales. Revenues from instruments +31%, consumables +12%, medical market sales -18%, medical sales worldwide, excluding sales to the U.S. government, -20%. Shares -5.8% AH. Comment! [Earnings, Healthcare, On the Move]
Thursday, April 25, 5:13 PM Abaxis (ABAX): Q1 EPS of $0.30 beats by $0.04. Revenue of $50M (+17% Y/Y) misses by $2.62M. Shares -5.8% AH. (PR) Comment! [Earnings, Breaking News, Healthcare, On the Move]
Friday, February 1, 12:45 PM Midday top 10 gainers: OTT +31%. ALIM +25%. BBW +22%. ADNC +21%. PSDV +16%. EDAP +16%. ABAX +15%. CRR +14%. CIS +11%. PMCS +12%.
Midday top 10 Losers: ECTE -31%. EBOD -28%. BCOV -23%. CKH -22%. LTM -20%. KERX -17%. CLSN -14%. SDR -14%. CBMX -11%. PXLW -11%. Comment! [On the Move]
Thursday, January 31, 5:45 PM After-hours top gainers, as of 5:15 p.m.: ADNC +26%. TSYS +13%. PMCS +7%. N +7%. ABAX +5%.
After-hours top losers: CPSI -9%. OPLK -6%. BEBE -4%. ELX -4%. LTM -4%. Comment! [On the Move]
Thursday, January 31, 4:59 PM Abaxis (ABAX): FQ3 EPS of $0.22 beats by $0.02. Revenue of $49.8M (+32% Y/Y) beats by $4.05M. Shares +6% AH. (PR) Comment! [Earnings, Breaking News, On the Move, Healthcare]
Thursday, December 6, 2012, 5:51 PM Abaxis (ABAX) declares special dividend of $1.00/share. For shareholders of record Dec. 17. Payable Dec. 28. Ex-div date Dec. 13. (PR) Comment! [Dividends]
Tuesday, October 23, 2012, 4:55 PM Abaxis (ABAX): FQ2 EPS of $0.18 in-line. Revenue of $44.3M (+11% Y/Y) misses by $2.5M. (PR) Comment! [Earnings, Healthcare]
Thursday, July 26, 2012, 5:27 PM Abaxis (ABAX): FQ1 EPS of $0.13 misses by $0.04. Revenue of $42M (+16.7% Y/Y) beats by $1.63M. Shares -2.4% AH. (PR) Comment! [Earnings, On the Move]
Friday, April 27, 2012, 12:13 PM Abaxis (ABAX +10.8%) pops after its FQ4 results easily topped estimates on a 14% Y/Y jump in revenue. Net profit leapt 40% over the prior year period on a 25% jump in sales of medical and veterinary instruments. Comment! [Healthcare, Earnings, On the Move]
Thursday, April 26, 2012, 5:03 PM Abaxis (ABAX): FQ4 EPS of $0.21 beats by $0.05. Revenue of $42.7M (+13.9% Y/Y) beats by $2M. Shares +8.9% AH. (PR) Comment! [Earnings, Healthcare, On the Move]
Friday, April 20, 2012, 2:57 PM Abaxis' (ABAX +10%) hopes for its veterinary medical products business enjoy a boost from Idexx Laboratories' (IDXX -1%) strong Q1 report which says its veterinarian business posted its strongest organic sales growth in years. Comment! [Healthcare, On the Move]
Friday, January 27, 2012, 11:50 AM Abaxis (ABAX -7.1%) dips after its FQ3 earnings missed the mark on both revenue and a per share basis. Profit from instrument sales decreased 2% Y/Y, primarily due to a slowdown in its European markets and distributor inventory adjustments. Comment! [Healthcare, On the Move]
Thursday, January 26, 2012, 4:25 PM Abaxis (ABAX): FQ3 EPS of $0.13 misses by $0.03. Revenue of $37.8M (+6% Y/Y) misses by $3M. (PR) Comment! [Earnings, Healthcare]
Wednesday, October 26, 2011, 11:15 AM Medical products supplier Abaxis (ABAX +16%) pops after its FQ2 easily beats estimates. Revenues rose 13% Y/Y on a jump in veterinary product and medical instrument sales, plus solid growth in its European and Asian markets. Separately, the company also approves $40M stock buyback program. Comment! [Healthcare, On the Move]
Friday, July 29, 2011, 4:19 PM Medical products company Abaxis (ABAX) finishes the day in the red, dropping -14.5% after reporting FQ1 earnings that missed expectations. International bookings took a hit due to timing issues with orders through its distributors. CEO Clint Severson summed up the quarter as "a period of investment for future growth." Comment! [Healthcare, Earnings, On the Move]

Michael Bryant
ABAXIS ($ABAX), Jazz Pharmaceuticals ($JAZZ), Oaktree Capital ($OAK), Apogee Enterprises ($APOG), & Stepan ($SCL) rose Monday on unusual vol
Mar 12, 4:04 AM
Reply (1)

• !Report Abuse
View all 1 replies
Michael Bryant: However, the only one I'll buy is Jazz Pharmaceuticals ($JAZZ).
Mar 12, 4:05 AM
• !Report Abuse
Add a reply...

140 characters

ZetaKap
7 Low-Debt Small Cap Healthcare Stocks Positioned For Growth http://bit.ly/QXzJu7 $ABAX $EXAS $GIVN $LMNX $OSUR $SPNC $TSRO @ZetaKap
8/21/12
Reply

• !Report Abuse
View all 0 replies
Add a reply...

140 characters

ZetaKap
4 Small Cap Healthcare Stocks Armed With Cash And Set For Growth http://bit.ly/KXcjZN $ABAX $AUXL $AVNR $ATRS @ZetaKap
6/25/12
Reply

• !Report Abuse
View all 0 replies
Add a reply...

140 characters

ZetaKap
Latest: 6 Small Cap Stocks With Plenty Of Cash On Hand And Strong Expected Growth http://bit.ly/JTMHfJ $AEIS $AFFX $ABAX $ABMD $ACOR $ADTN
5/24/12
Reply

• !Report Abuse
View all 0 replies
Add a reply...

140 characters

ZetaKap
6 Low-Debt Healthcare Stocks With Strong Analysts Ratings http://bit.ly/J1bs3p $ACHN $AFFY $ACAD $ABAX $AEGR $ACOR @ZetaKap
5/17/12
Reply

• !Report Abuse
View all 0 replies
Add a reply...

140 characters

ZetaKap
$$ Our Newest: 6 Cash Heavy Small-Cap Healthcare Stocks Rated As Buys http://bit.ly/K5XVsA $ARTC $AKRX $ACOR $AVNR $AUXL $ABAX @ZetaKap
5/10/12
Reply

• !Report Abuse
View all 0 replies
Add a reply...

140 characters

The Wall Street Transcript
Pets & Vets: Investment Returns from our Animal Companions Part 3- http://su.pr/1beJYM $OME, $ABAX, $MWIV, $WOOF, $PDCO, $IDXX, $TSCO, $PETM
12/23/11
Reply (4)

• !Report Abuse
View all 4 replies
The Wall Street Transcript: that's an end of year tax planning decision. are you looking for tax losses or gains? stock seems fully valued but recession resistant.
12/27/11
• !Report Abuse
FortSumter: I agree. Stock seems fully valued @$52 with a 50ma of $48 maybe a 10% pullback would be reasonably anticipated with any macro bad news.
12/27/11
• !Report Abuse
Add a reply...

140 characters

Menzoit
HRBN will drift to $22 The interests of the CEO, ABAX, the CDB and shareholders are alligned. The due diligence has already been vetted
6/21/11
Reply

• !Report Abuse
View all 0 replies
Add a reply...

140 characters

Ryan Mallory
Here's some stocks ready for a massive squeeze: ABAX CBZ CHUX FRED GHDX HEI INWK ONCY RUTH VIVO http://bit.ly/jHbbfU
6/9/11
Reply

• !Report Abuse
View all 0 replies
Add a reply...

140 characters

Michael Bryant
Abaxis (ABAX) is breaking out. Valhi (VHI) seems on the run and is a great stock to own.
5/20/11
Reply

• !Report Abuse
View all 0 replies
Add a reply...

140 characters

LATEST REPLIES

Michael Bryant
ABAXIS ($ABAX), Jazz Pharmaceuticals ($JAZZ), Oaktree Capital ($OAK), Apogee Enterprises ($APOG), & Stepan ($SCL) rose Monday on unusual vol
Mar 12, 4:04 AM
Reply (1)

• !Report Abuse
View all 1 replies
Michael Bryant: However, the only one I'll buy is Jazz Pharmaceuticals ($JAZZ).
Mar 12, 4:05 AM
• !Report Abuse
Add a reply...

140 characters

The Wall Street Transcript
Pets & Vets: Investment Returns from our Animal Companions Part 3- http://su.pr/1beJYM $OME, $ABAX, $MWIV, $WOOF, $PDCO, $IDXX, $TSCO, $PETM
12/23/11
Reply (4)

• !Report Abuse
View all 4 replies
The Wall Street Transcript: that's an end of year tax planning decision. are you looking for tax losses or gains? stock seems fully valued but recession resistant.
12/27/11
• !Report Abuse
FortSumter: I agree. Stock seems fully valued @$52 with a 50ma of $48 maybe a 10% pullback would be reasonably anticipated with any macro bad news.
12/27/11
• !Report Abuse
Add a reply...

140 characters

ABAX ABAXIS, Inc.

ABAX

ABAXIS, Inc.